Cargando…
Therapeutic regimen of l-arginine for MELAS: 9-year, prospective, multicenter, clinical research
OBJECTIVE: To examine the efficacy and safety of the therapeutic regimen using oral and intravenous l-arginine for pediatric and adult patients with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS). METHODS: In the presence and absence of an ictus of stroke-l...
Autores principales: | Koga, Yasutoshi, Povalko, Nataliya, Inoue, Eisuke, Nakamura, Hidefumi, Ishii, Akiko, Suzuki, Yasuhiro, Yoneda, Makoto, Kanda, Fumio, Kubota, Masaya, Okada, Hisashi, Fujii, Katsunori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6244654/ https://www.ncbi.nlm.nih.gov/pubmed/30269300 http://dx.doi.org/10.1007/s00415-018-9057-7 |
Ejemplares similares
-
l-Arginine intervention at hyper-acute phase protects the prolonged MRI abnormality in MELAS
por: Kitamura, Miyuki, et al.
Publicado: (2016) -
Arginine therapy in mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes
por: Ikawa, Masamichi, et al.
Publicado: (2020) -
A new diagnostic indication device of a biomarker growth differentiation factor 15 for mitochondrial diseases: From laboratory to automated inspection
por: Koga, Yasutoshi, et al.
Publicado: (2020) -
The effect of citrulline and arginine supplementation on lactic acidemia in MELAS syndrome()
por: El-Hattab, Ayman W., et al.
Publicado: (2013) -
Arrhythmias in MELAS syndrome
por: Finsterer, Josef, et al.
Publicado: (2016)